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Introduction
• Actinic keratoses (AKs)
are precancerous skin
lesions that are very
common
• AK patients are at a
higher risk of developing
skin cancer

Methods
• We conducted a retrospective cohort study using
a de-identified, random` sample of 4,999,999
Medicare beneficiaries aged ≥ 65 from 20092018.
*Principal AK = first AK
diagnosis after having been in
dataset for at least one year

• The follow-up patterns
and skin cancer
surveillance for AK
patients is relatively
unknown

Objective
To understand the follow-up
frequencies and skin cancer
surveillance patterns in a large
sample of actinic keratoses
patients utilizing claims data

• We assessed the demographics and clinical
characteristics of patients to determine their skin
history.
• Our primary goal was to evaluate if patients had a
total body skin check within 1 year of an AK
diagnosis.

Results
64.14 % patients
with at least one
actinic keratoses
diagnosis were
seen back for a skin
cancer surveillance
exam within 12
months

Conclusion
• AK follow up for 12 months
is lower than what we would
have expected
• Next steps: Correlation
between frequency of
follow-up visits and skin
cancer development
• Understanding the current
patterns in skin cancer
surveillance for AK patients
is important to guide the
creation of evidence-based
recommendations for this
high-risk population
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